Standout Papers
Citation Impact
Citing Papers
Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation
2013 StandoutScience
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
2020 StandoutScienceNobel
Interim evaluation of two cooperative studies assessing the effects of intravenous immunoglobulin (i.v. IgG) on childhood idiopathic thrombocytopenic purpura (ITP)
1984
Comprehensive molecular portraits of human breast tumours
2012 StandoutNature
Effectiveness of a hospital-wide programme to improve compliance with hand hygiene
2000 Standout
Intravenous high-dose igg therapy induced alterations of spleen lymphocyte igm secretion and t cell subsets in patients with idiopathic thrombocytopenic purpura
1987
Passive Immunotherapy in AIDS: A Randomized Trial of Serial Human Immunodeficiency Virus-Positive Transfusions of Plasma Rich in p24 Antibodies versus Transfusions of Seronegative Plasma
1992 StandoutNobel
A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies
2003 Standout
Acute pain induces an instant increase in natural killer cell cytotoxicity in humans and this response is abolished by local anaesthesia
1999
Cytogenetic, Molecular Genetic, and Clinical Characteristics of Acute Myeloid Leukemia With a Complex Karyotype
2008
Acute immune thrombocytopenic purpura: A comparative study of very high oral doses of methylprednisolone and intravenously administered immune globulin
1994
Childhood ITP: 12 months follow‐up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS)
2005
Myasthenia Gravis
2016 Standout
Marriage and health: His and hers.
2001 Standout
Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin
1999
Manipulating the Immune System with Immune Globulin
1992
Small-Vessel Vasculitis
1997 Standout
Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease
1994
The β-Thalassemias
1999 Standout
Langerhans'-Cell Histiocytosis (Histiocytosis X) -- A Clonal Proliferative Disease
1994 Standout
Long-Term Danazol Therapy in Autoimmune Thrombocytopenia: Unmaintained Remission and Age-Dependent Response in Women
1989
High dose intravenous methylprednisolone or high dose intravenous gammaglobulin for autoimmune thrombocytopenia
1988
Fc receptors and their interaction with complement in autoimmunity
2005
Low-Dose Versus High-Dose Immunoglobulin for Primary Treatment of Acute Immune Thrombocytopenic Purpura in Children: Results of a Prospective, Randomized Single-Center Trial
2003
Severe Congenital Neutropenia
2006
Guillain-Barré syndrome
2016 Standout
Glycosylation in Cellular Mechanisms of Health and Disease
2006 Standout
IgG Fc Glycosylation in Human Immunity
2019
The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease
2015
Epigenetic gene silencing in cancer: the DNA hypermethylome
2007
Clinical trial of plasma exchange and high‐dose intravenous immunoglobulin in myasthenia gravis
1997
Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study
2002 Standout
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people
2010
Treatment of Antineutrophil Cytoplasm Autoantibody-Associated Systemic Vasculitis: Initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group
1997
A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome
1991 Standout
Intravenous immunoglobulin: regulatory perspectives on use and supply
2001
Immediate effects of intravenous IgG administration on peripheral blood B and T cells and polymorphonuclear cells in patients with myasthenia gravis
1988
Fcγ receptors as regulators of immune responses
2007 Standout
Myasthenia Gravis
1994 Standout
Platelet‐reactive IgG antibodies cloned by phage display and panning with IVIG from three patients with autoimmune thrombocytopenia
1999
DNA Damage, Aging, and Cancer
2009 Standout
Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura
1994
A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura
1993
Oral Megadose Methylprednisolone Versus Intravenous Immunoglobulin for Acute Childhood Idiopathic Thrombocytopenic Purpura
1993
High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.
1994
Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: An open study with 20 adult patients
1991
Chronic Health Conditions in Adult Survivors of Childhood Cancer
2006 Standout
Mechanisms of action of intravenous immunoglobulin therapy and potential use in autoimmune connective tissue diseases
1991
Iron Chelators for Thalassaemia
1998
Immune Thrombocytopenic Purpura
2002 Standout
Graft-versus-host disease
2009 Standout
Removal of cells from a malignant B-cell line from bone marrow with immunomagnetic beads and with complement and immunoglobulin switch variant mediated cytolysis
1987
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Experience with intravenous immunoglobulin in myasthenia gravis
1989
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
The trinity of COVID-19: immunity, inflammation and intervention
2020 Standout
Immunomodulation by IVIg and the Role of Fc-Gamma Receptors: Classic Mechanisms of Action after all?
2015
Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors
2004
Major hemorrhage in children with idiopathic thrombocytopenic purpura: Immediate response to therapy and long-term outcome
1998
Fc receptor blockade and immune thrombocytopenic purpura
2000
Pulse methylprednisolone therapy for acute childhood idiopathic thrombocytopenic purpura
1988
The Dynamic Properties and Possible Functions of Nuclear Lamins
1996
Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura
1993
Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura: results of a randomized trial comparing 0.5 and 1 g/kg b.w.
1999
Clinical implications of ELA2‐, HAX1‐, and G‐CSF‐receptor (CSF3R) mutations in severe congenital neutropenia
2008
Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model.
1989
5 Thalassaemia: clinical management
1998
Iron-Chelation Therapy with Oral Deferiprone in Patients with Thalassemia Major
1995
Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature
2006
Points of control in inflammation
2002 StandoutNature
CDK Inhibitor p18INK4c Is a Downstream Target of GATA3 and Restrains Mammary Luminal Progenitor Cell Proliferation and Tumorigenesis
2009
Free radicals and antioxidants in chemotherapyinduced toxicity
1997
Long-Term Safety and Effectiveness of Iron-Chelation Therapy with Deferiprone for Thalassemia Major
1998
Guillain-Barr?? Syndrome
2004
Randomized trial comparing intravenous immunoglobulin with methylprednisolone pulse therapy in acute idiopathic thrombocytopenic purpura
1996
Clonal analysis of human tumors with M27 beta, a highly informative polymorphic X chromosomal probe.
1992
Polymyositis and dermatomyositis
2003 Standout
The antiinflammatory activity of IgG: the intravenous IgG paradox
2007
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
A- and B-type lamins are differentially expressed in normal human tissues
1997
Neutrophil recruitment and function in health and inflammation
2013 Standout
Guillain-Barré syndrome
2005 Standout
A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for Dermatomyositis
1993 Standout
Advances in understanding and treatment of immune‐mediated disorders of the peripheral nervous system
2004
Proteins Connecting the Nuclear Pore Complex with the Nuclear Interior
1999 StandoutNobel
Magnesium in Man: Implications for Health and Disease
2014 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Anti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor
2001 Science
Intravenous immunoglobulin for Guillain-Barré syndrome
2014
Current Options for the Treatment of Idiopathic Thrombocytopenic Purpura
2007
EFFECT OF INTRAVENOUS IMMUNOGLOBULIN IN IMMUNE THROMBOCYTOPENIA
1983
The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide ofStreptococcus pneumoniaein the marginal zone of mouse spleen
2003 StandoutNobel
Fc receptors in antibody‐dependent enhancement of viral infections
2015
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2
2020 Standout
WEGENER'S GRANULOMATOSIS
1995
The nontreatment of childhood idiopathic thrombocytopenic purpura
1987
Intravenous Immunoglobulin: Striving for Appropriate Use
2006
Reversal of Chronic Polymyositis Following Intravenous Immune Serum Globulin Therapy
1987
Deferiprone (L1) chelates pathologic iron deposits from membranes of intact thalassemic and sickle red blood cells both in vitro and in vivo
1995
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
2008 Standout
Intravenous Anti-D Treatment of Immune Thrombocytopenic Purpura: Experience in 272 Patients
1997
Complementary/Alternative Medicine Use in a Comprehensive Cancer Center and the Implications for Oncology
2000 Standout
Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy
1985
Treatment of Refractory Immune Thrombocytopenic Purpura with an Anti-Fcγ-Receptor Antibody
1986
Kawasaki Disease: A Brief History
2000
Intravenous Treatment with Gammaglobulin in Adults with Immune Thrombocytopenic Purpura: Review of the Literature1
1987
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin
1986 Standout
Activation and Differentiation of Autoreactive B-1 Cells by Interleukin 10 Induce Autoimmune Hemolytic Anemia in Fas-deficient Antierythrocyte Immunoglobulin Transgenic Mice
2002 StandoutNobel
HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR KAWASAKI DISEASE
1984
Intravenous immunoglobulin: Historical perspective
1987
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
1989 StandoutScience
Long-term Consequences of Kawasaki Disease
1996 Standout
Clinical Prediction Rules for Children: A Systematic Review
2011
Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals
1998
ANTI-IDIOTYPIC SUPPRESSION OF AUTOANTIBODIES TO FACTOR VIII (ANTIHAEMOPHILIC FACTOR) BY HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN
1984
A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura.
2004
Maintenance treatment of adults with chronic refractory immune thrombocytopenic purpura using repeated intravenous infusions of gammaglobulin [see comments]
1988
A Randomized Trial Comparing Intravenous Immune Globulin and Plasma Exchange in Guillain–Barré Syndrome
1992 Standout
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
2006 Science
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
Long‐Term Follow‐Up Study of 168 Patients with Immune Thrombocytopenia. Implications for Therapy
1984
Response of Resistant Idiopathic Thrombocytopenic Purpura to Pulsed High-Dose Dexamethasone Therapy
1994
Iron-Chelating Therapy and the Treatment of Thalassemia
1997
Leukemia and other Cancers, Anomalies and Infections as Causes of Death in Down's Syndrome in the United States during 1976
1982
Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: A report from the late effects surveillance system
2006
MANAGEMENT OF CHILDHOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA
1983
ROLE OF MASSIVE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN NON-HODGKIN'S MALIGNANT LYMPHOMA
1984
Takayasu's Arteritis and Ankylosing Spondylitis Report of Four Cases
1966
Surgery of the Spleen
1983
Treatment of acute idiopathic thrombocytopenic purpura of childhood with intravenous immunoglobulin G: Comparative efficacy of 7S and 5S preparations
1986
Takayasu's Arteritis
1967 Standout
LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia
2006 Standout
A multiinstitutional survey of the Wiskott-Aldrich syndrome
1994
Works of Andreas Hirt being referenced
Haemophilia due to factor VIII inhibitors in a patient suffering from an autoimmune disease: Treatment with intravenous immunoglobulin
1984
Identification of children presenting with fever in chemotherapy‐induced neutropenia at low risk for severe bacterial infection
2003
Repression of nuclear lamin A and C gene expression in human acute lymphoblastic leukemia and non-Hodgkin's lymphoma cells
1990
Immunogenotyping with antigen receptor gene probes as a diagnostic tool in childhood acute lymphoblastic leukaemia
1990
Intravenous immunoglobulin (i.v. IgG) for previously treated acute or for chronic idiopathic thrombocytopenic purpura (ITP) in childhood: a prospective multicenter study
1988
Immunthrombocytopenic purpura as a model for pathogenesis and treatment of autoimmunity
1995
Persisting Renotubular Sequelae after Cisplatin in Children and Adolescents
1991
Liver iron and fibrosis during long‐term treatment with deferiprone in Swiss thalassaemic patients
1998
Chronic renal magnesium loss, hypocalciuria and mild hypokalaemic metabolic alkalosis after cisplatin
1990
High incidence of significant bone loss in patients with severe congenital neutropenia (Kostmann’s syndrome)
1997
MCM4 shares homology to a replication/DNA-binding domain in CTF and is contacted by pRb
2004
CEREBROSPINAL FLUID INFLAMMATION INDUCED BY INTRAVENOUS IMMUNOGLOBULINS
1992
L1 (1,2‐dimethyl‐3‐hydroxypyrid‐4‐one) for oral iron chelation in patients with beta‐thalassaemia major
1990
Autologous bone marrow transplantation in the treatment of children and adolescents with advanced malignant tumors
1984
Autologous bone-marrow transplantation for Burkitt's lymphoma: marrow purging with anti-Y 29/55 monoclonal antibody and complement.
1985
High-dose intravenous gammaglobulin therapy of refractory, in particular idiopathic thrombocytopenia in childhood.
1981
Effect of cations and cation channel blockers on human natural killer cells
1985
The prognostic significance of cytogenetic aberrations in childhood acute myeloid leukaemia. A study of the Swiss Paediatric Oncology Group (SPOG)
2007
[High-dose immunoglobulin infusions in idiopathic thrombopenic purpura].
1983
Nuclear lamin expression reveals a surprisingly high growth fraction in childhood acute lymphoblastic leukemia cells.
1994
Intravenous immunoglobulin for idiopathic thrombocytopenic purpura (ITP) in childhood
1984
HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD
1981 Standout